跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 396 条关于
“Haitao Hu”
全部
396
临床试验
200
药物
93
机构
22
资讯
81
上个月
China Poaches 105 Top US Scientists as Biotech Brain Drain Accelerates
去年
Gecacitinib Demonstrates Superior Spleen Volume Reduction in Myelofibrosis Patients Compared to Hydroxyurea
去年
Gecacitinib Shows Superior Efficacy and Safety Over Hydroxyurea in Myelofibrosis Patients
5年前
Interferon-Alpha Shows Promise in Reducing Myelofibrosis Risk and Mortality in Polycythemia Vera Patients
2个月前
Botanicure's Botanical Drug BOTA-NS1 Shows Early Promise for Cognitive Decline in Pilot Study
3年前
Ropeginterferon Alfa-2b Shows Promise as Second-Line Treatment for High-Risk Essential Thrombocythemia
3年前
Ropeginterferon Alfa-2b Shows Promise in Hydroxyurea-Resistant Essential Thrombocythemia
去年
University of Wisconsin Researchers Develop Personalized Cancer Vaccines Using Pyroptotic Vesicles to Prevent Tumor Recurrence
4个月前
C-Ray Therapeutics Secures FDA Approval for Copper-64 Drug Master File, Advancing Next-Generation PET Diagnostics
4个月前
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance AI-Driven Drug Discovery Platform
第 1 页,共 9 页
上一页
下一页